Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07033-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Tong Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95Th, Yongan Road, Beijing, 100050, China. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin G4-Related Disease, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research, Tongzhou District Science and Technology Committee.
Abstract (Originalsprache)
BACKGROUND: To systematically describe clinical characteristics and investigate factors associated with COVID-19-related infection, hospital admission, and IgG4-related disease relapse in IgG4-RD patients. METHODS: Physician-reported IgG4-RD patients were included in this retrospective study. Using multivariable logistic regression analysis to determine factors for primary outcome (COVID-19-related IgG4-RD relapse) and secondary outcome (COVID-19-related infection and hospital admission). Covariates included age, sex, body mass index, smoking status, comorbidities, IgG4-RD clinical features, and treatment strategies. RESULTS: Among 649 patients, 530 had a diagnosis of COVID-19, 25 had COVID-19-related hospital admission, and 69 had COVID-19-related IgG4-RD relapse. Independent factors associated with COVID-19 infection were age (OR, 0.98; 95% CI, 0.96-1.00), body mass index (1.10, 1.03-1.18), and tofacitinib (0.34, 0.14-0.79). Further analysis indicated that age (1.10, 1.03-1.16), coronary heart disease (24.38, 3.33-178.33), COVID-19-related dyspnea (7.11, 1.85-27.34), pulmonary infection (73.63, 16.22-4615.34), and methotrexate (17.15, 1.93-157.79) were associated with a higher risk of COVID-19-related hospital admission. Importantly, age (0.93, 0.89-0.98), male sex (0.16, 0.03-0.80), ever/current smoking (19.23, 3.78-97.80), COVID-19-related headache (2.98, 1.09-8.17) and psychiatric symptoms (3.12, 1.07-9.10), disease activity before COVID-19 (1.89, 1.02-3.51), number of involved organs (1.38, 1.08-1.76), glucocorticoid dosage (1.08, 1.03-1.13), and methotrexate (5.56, 1.40-22.08) were strong factors for COVID-19-related IgG4-RD relapse. CONCLUSIONS: Our data add to evidence that smoking and disease-specific factors (disease activity, number of involved organs, and specific medications) were risk factors of COVID-19-related IgG4-RD relapse. The results highlight the importance of adequate disease control with b/tsDMARDs, preferably without using methotrexate and increasing glucocorticoid dosages in the COVID-19 era. Key Points • COVID-19-related infection or hospital admission were associated with known general factors (age, body mass index, specific comorbidities and methotrexate) among IgG4-RD patients. • Smoking and disease-specific factors (disease activity, number of involved organs and specific medications) were associated with higher odds of COVID-19-related IgG4-RD relapse. • The results highlight the importance of adequate disease control with b/tsDMARDs, preferably without using methotrexate or increasing glucocorticoid dosages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95Th, Yongan Road, Beijing, 100050, China.
- Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95Th, Yongan Road, Beijing, 100050, China. Liuyanying6850@126.com.
Förderung
- Capital's Funds for Health Improvement and Research
- Tongzhou District Science and Technology Committee
Zitieren
APA
Zhang, T., Liu, H., Tian, M., Zhou, M., Zhou, H., Zhang, X., Wang, T., Bai, M., Xu, Y., Yang, F., Zhufeng, Y., Hao, Q., Lian, D., Zeng, W., Song, S., Qi, H., & Liu, Y. (2024). Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07033-z
Vancouver
Zhang T, Liu H, Tian M, Zhou M, Zhou H, Zhang X, et al. Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07033-z
BibTeX
@article{Zhang2024,
author = {Zhang, Tong and Liu, Huilan and Tian, Mengxin and Zhou, Mingzhu and Zhou, Hang and Zhang, Xia and Wang, Tianqi and Bai, Mingxin and Xu, Yuetong and Yang, Fan and Zhufeng, Yunzhi and Hao, Qiyuan and Lian, Difei and Zeng, Wenhuan and Song, Shuju and Qi, Haiyu and Liu, Yanying},
title = {Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07033-z}
}
EUVIMED